Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07467668 · ClinicalTrials.gov registry record · NA
Infusing Needed Iron to Target Insufficiency in Adults Treated for Evidence of Heart Failure
A NA study, sponsored by Kaiser Permanente.
- Not yet
- Registry status
- NA
- Development phase
- 3,000
- Enrollment target
NCT07467668 is a NA study that has not yet begun recruiting, run by Kaiser Permanente. The registered enrollment target is 3,000 participants.
The verdict
NCT07467668, a NA study, has not yet begun recruiting, sponsored by Kaiser Permanente.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 3,000 participants
- Enrollment target
Study Summary
The INITIATE-HF study is a cluster randomized controlled trial that aims to find out if reminding doctors about treatment guidelines for iron deficiency in adults with heart failure who are hospitalized and have evidence of iron deficiency changes the subsequent use of intravenous (IV) iron. Two groups of hospitalized adult patients with known heart failure and iron deficiency will be compared: * Group 1 will include doctors who receive a notification with their patient's iron storage test results and guideline recommendations related to the use of IV iron. * Group 2 will include doctors who do not receive this notification and continue with usual standard of care. The study will measure if this provider-facing notification affects physician use of recommended IV iron treatment in eligible patients with heart failure, left ventricular ejection fraction less than 50%, and iron deficiency. Secondarily, if there is an increased use of IV iron observed in the intervention group, this study will evaluate whether there are differential health outcomes (i.e., fewer subsequent hospital visits and lower risk of death) of patients whose providers were assigned to the intervention group.
Interventions
- OTHER Notification Group
- OTHER No Notification Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2026-03-09 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07467668
The ClinicalTrials.gov registry entry for NCT07467668 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Notification Group is the first listed.
NCT07467668 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07467668 about?
NCT07467668 is a clinical study titled "Infusing Needed Iron to Target Insufficiency in Adults Treated for Evidence of Heart Failure". The INITIATE-HF study is a cluster randomized controlled trial that aims to find out if reminding doctors about treatment guidelines for iron deficiency in adults with heart failure who are hospitalized and have evidence of iron deficiency changes the subsequent use of intravenous (IV) iron. Two gr...
What is the current status of trial NCT07467668?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2026-03-09. Estimated completion is 2028-12-31.
What interventions are being tested in trial NCT07467668?
The interventions under investigation include: Notification Group (OTHER), No Notification Group (OTHER).
Who is sponsoring clinical trial NCT07467668?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.